Topoisomerase inhibitor, Moxifloxacin HCl, Purity ≥98%

Synonym: 186826-86-8; Avelox; Avalox; BAY 12-8039; 7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-Octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid; hydrochloride

MDL: MFCD00949117
CAS Number: 186826-86-8
Compound CID: 101526

Product Size

50 mg; 100 mg; 200 mg; 500 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Moxifloxacin HCl, soluble in DMSO and water and insoluble in ethanol, is an effective DNA damage inhibitor, that has the ability to prevent the pathway of DNA damage by inhibiting topoisomerase.

Molecular Weight

437.9

Molecular Formula

C₂₁H₂₄FN₃O₄·HCl

Form

Lyophilized powder

Purity

≥98%

Titer

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects

Solubility

In vitro: DMSO: 77 mg/mL (175.84 mM); Water: 53 mg/mL (121.03 mM); Ethanol: insoluble; In vivo: 30% PEG400 + 0.5% Tween80 + 5% propylene glycol, 28 mg/mL

Applications

Moxifloxacin HCl is a DNA damage inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of infections such as respiratory tract infections, skin infections, and intra-abdominal infections.